These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 15953866)

  • 61. Statins and bone: myth or reality?
    Edwards CJ; Russell RG; Spector TD
    Calcif Tissue Int; 2001 Aug; 69(2):63-6. PubMed ID: 11683424
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of statins on bone mineral density and bone histomorphometry in rodents.
    Maritz FJ; Conradie MM; Hulley PA; Gopal R; Hough S
    Arterioscler Thromb Vasc Biol; 2001 Oct; 21(10):1636-41. PubMed ID: 11597938
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pitavastatin enhanced BMP-2 and osteocalcin expression by inhibition of Rho-associated kinase in human osteoblasts.
    Ohnaka K; Shimoda S; Nawata H; Shimokawa H; Kaibuchi K; Iwamoto Y; Takayanagi R
    Biochem Biophys Res Commun; 2001 Sep; 287(2):337-42. PubMed ID: 11554731
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Simvastatin increases serum osteocalcin concentration in patients treated for hypercholesterolaemia.
    Chan MH; Mak TW; Chiu RW; Chow CC; Chan IH; Lam CW
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4556-9. PubMed ID: 11549708
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The effect of fluvastatin on parameters of bone remodeling.
    Bjarnason NH; Riis BJ; Christiansen C
    Osteoporos Int; 2001; 12(5):380-4. PubMed ID: 11444086
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of statins on biomarkers of bone metabolism: a randomised trial.
    Stein EA; Farnier M; Waldstreicher J; Mercuri M;
    Nutr Metab Cardiovasc Dis; 2001 Apr; 11(2):84-7. PubMed ID: 11434192
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pravastatin therapy increases procollagen I N-terminal propeptide (PINP), a marker of bone formation in post-menopausal women.
    Mostaza JM; De la Piedra C; Curiel MD; Peña R; Lahoz C
    Clin Chim Acta; 2001 Jun; 308(1-2):133-7. PubMed ID: 11412825
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Compactin enhances osteogenesis in murine embryonic stem cells.
    Phillips BW; Belmonte N; Vernochet C; Ailhaud G; Dani C
    Biochem Biophys Res Commun; 2001 Jun; 284(2):478-84. PubMed ID: 11394905
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Use of statins and risk of fractures.
    van Staa TP; Wegman S; de Vries F; Leufkens B; Cooper C
    JAMA; 2001 Apr; 285(14):1850-5. PubMed ID: 11308398
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial. Long-term Intervention with Pravastatin in Ischaemic Disease.
    Reid IR; Hague W; Emberson J; Baker J; Tonkin A; Hunt D; MacMahon S; Sharpe N
    Lancet; 2001 Feb; 357(9255):509-12. PubMed ID: 11229669
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells.
    Maeda T; Matsunuma A; Kawane T; Horiuchi N
    Biochem Biophys Res Commun; 2001 Jan; 280(3):874-7. PubMed ID: 11162604
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Oral statins and increased bone-mineral density in postmenopausal women.
    Edwards CJ; Hart DJ; Spector TD
    Lancet; 2000 Jun; 355(9222):2218-9. PubMed ID: 10881898
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women.
    Chan KA; Andrade SE; Boles M; Buist DS; Chase GA; Donahue JG; Goodman MJ; Gurwitz JH; LaCroix AZ; Platt R
    Lancet; 2000 Jun; 355(9222):2185-8. PubMed ID: 10881890
    [TBL] [Abstract][Full Text] [Related]  

  • 74. HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients.
    Wang PS; Solomon DH; Mogun H; Avorn J
    JAMA; 2000 Jun; 283(24):3211-6. PubMed ID: 10866868
    [TBL] [Abstract][Full Text] [Related]  

  • 75. HMG-CoA reductase inhibitors and the risk of fractures.
    Meier CR; Schlienger RG; Kraenzlin ME; Schlegel B; Jick H
    JAMA; 2000 Jun; 283(24):3205-10. PubMed ID: 10866867
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Compactin and simvastatin, but not pravastatin, induce bone morphogenetic protein-2 in human osteosarcoma cells.
    Sugiyama M; Kodama T; Konishi K; Abe K; Asami S; Oikawa S
    Biochem Biophys Res Commun; 2000 May; 271(3):688-92. PubMed ID: 10814523
    [TBL] [Abstract][Full Text] [Related]  

  • 77. HMG-CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients.
    Chung YS; Lee MD; Lee SK; Kim HM; Fitzpatrick LA
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1137-42. PubMed ID: 10720052
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Stimulation of bone formation in vitro and in rodents by statins.
    Mundy G; Garrett R; Harris S; Chan J; Chen D; Rossini G; Boyce B; Zhao M; Gutierrez G
    Science; 1999 Dec; 286(5446):1946-9. PubMed ID: 10583956
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Thyroid hormone excess increases insulin-like growth factor I transcripts in bone marrow cell cultures: divergent effects on vertebral and femoral cell cultures.
    Milne M; Kang MI; Quail JM; Baran DT
    Endocrinology; 1998 May; 139(5):2527-34. PubMed ID: 9564868
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Bone morphogenetic protein-2 and transforming growth factor-beta2 interact to modulate human bone marrow stromal cell proliferation and differentiation.
    Fromigué O; Marie PJ; Lomri A
    J Cell Biochem; 1998 Mar; 68(4):411-26. PubMed ID: 9493905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.